Table 2.
Summary Patient Characteristics of Included Studies
| Characteristic | MSM | MSW | Women | Men With Unknown MSM Status | Unknown Gender, MSM Status | Statistical Significance (P Value)a | ||
|---|---|---|---|---|---|---|---|---|
| MSM vs MSW | MSM vs Women | MSW vs Women | ||||||
| Total HIV negative | 114 (36.7) | 10 (3.2) | 74 (23.8) | 104 (33.4) | 9 (2.9) | |||
| Age, y, mean (SD) | 33.7 (11.0) | 46.1 (5.7) | 40.1 (9.3)a | 42.1 (13.1)b | Unknownc | <.01 | <.01 | .05 |
| Race | ||||||||
| White | 53 (46.5) | 8 (80.0) | 30 (40.5) | 29 (27.9) | 0 (0.0) | .17 | .19 | .31 |
| Black | 51 (44.7) | 2 (20.0) | 24 (32.4) | 27 (26.0) | 0 (0.0) | |||
| Latino | 4 (3.5) | 0 (0.0) | 6 (8.1) | 10 (9.6) | 0 (0.0) | |||
| Asian | 0 (0.0) | 0 (0.0) | 1 (1.4) | 2 (1.9) | 0 (0.0) | |||
| Other | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |||
| Unknown | 6 (5.3) | 0 (0.0) | 13 (17.6) | 36 (34.6) | 9 (100) | |||
| Total HIV positive | 323 (44.8) | 107 (14.8) | 171 (23.7) | 89 (12.3) | 31 (4.3) | |||
| Age, y, mean (SD) | 37.7 (11.3)d | 48.3 (7.9)e | 41.8 (10.6)a | 40.9 (9.9)f | Unknownc | <.001 | <.001 | <.001 |
| Race | ||||||||
| White | 145 (44.9) | 83 (77.6) | 59 (34.5) | 24 (27.0) | 0 (0.0) | <.001 | <.001 | <.001 |
| Black | 74 (22.9) | 12 (11.2) | 80 (46.8) | 32 (36.0) | 0 (0.0) | |||
| Latino | 51 (15.8) | 8 (7.5) | 11 (6.4) | 3 (3.4) | 0 (0.0) | |||
| Asian | 0 (0.0) | 0 (0.0) | 4 (2.3) | 1 (1.1) | 0 (0.0) | |||
| Other | 1 (0.3) | 1 (0.9) | 2 (1.2) | 1 (1.1) | 0 (0.0) | |||
| Unknown | 52 (16.1) | 3 (2.8) | 15 (8.8) | 28 (31.5) | 31 (100) | |||
| CD4 count, cells/µL | ||||||||
| <200 | 24 (7.4) | 11 (10.3) | 21 (12.3) | 15 (16.9) | 0 (0.0) | .36 | .08 | .61 |
| ≥200 | 297 (92.0) | 96 (89.7) | 150 (87.7) | 74 (83.1) | 0 (0.0) | |||
| Unknown | 2 (0.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 31 (100) | |||
| Viral load | ||||||||
| <400 | 157 (48.6) | 71 (66.4) | 91 (53.2) | 46 (51.7) | 0 (0.0) | .001 | .28 | .02 |
| ≥400 | 163 (50.5) | 33 (30.8) | 77 (45.0) | 31 (35.8) | 0 (0.0) | |||
| Unknown | 3 (0.9) | 3 (2.8) | 3 (1.8) | 12 (13.5) | 31 (100) | |||
| ART use | ||||||||
| No | 136 (42.1) | 46 (43.0) | 94 (55.0) | 30 (33.7) | 0 (0.0) | .68 | .04 | .05 |
| Yes | 164 (50.8) | 61 (57.0) | 77 (45.0) | 59 (66.3) | 0 (0.0) | |||
| Unknown | 23 (7.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 31 (100) |
Data are presented as no. (%) unless otherwise indicated. P values represent χ2 analysis. Based on Bonferroni correction, statistical significance set at P <.02.
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; MSM, men who have sex with men; MSW, men who have sex with women; SD, standard deviation.
aMissing age on 5 individuals.
bMissing age on 16 individuals.
cMissing age on all individuals.
dMissing age on 25 individuals.
eMissing age on 1 individual.
fMissing age on 3 individuals.
gExcludes unknown categories.